Mechanical Thrombectomy and Catheter Directed Thrombolysis Utilization in Patients With Deep Vein Thrombosis
NCT ID: NCT06468150
Last Updated: 2024-06-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2427 participants
OBSERVATIONAL
2022-01-01
2024-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. How many patients with deep vein thrombosis are potentially eligible for mechanical thrombectomy and catheter-directed thrombolysis in a tertiary hospital?
2. What is the actual number of patients undergoing endovascular interventions for deep vein thrombosis?
Participants received endovascular treatment according to the clinical protocol of the treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inferior Vena Cava Filters: Analysis of a Database
NCT04330170
Study of a Novel Thrombectomy Device to Treat Acute Iliofemoral Deep Venous Thrombosis
NCT02414802
Ongoing Registry of Treatment of Venous Thromboembolism
NCT03881345
Outcome of Percutaneous Mechanical Thrombectomy to Treat Acute Deep Venous Thrombosis
NCT02959801
Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism
NCT03044574
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pirogov Russian National Research Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Igor Zolotukhin
Professor of Surgery, Pirogov RNRMU, Zolotukhin Igor Anatolievich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Federal Budget-Funded Institution National Medical Surgical Center named after N. I. Pirogov of the Ministry of health of the Russian Federation
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
224/22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.